context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
Interest paid in cash, including note repurchase premiums, for the years ended December 31, 2024, 2023 and 2022 was $ 344 million, $ 301 million and $ 234 million, respectively. Cash interest for the years ended December 31, 2024, 2023 and 2022 included $ 0 , $ 3 million and $ 17 million of note repurchase premiums, respectively. | text | 344 | monetaryItemType | text: <entity> 344 </entity> <entity type> monetaryItemType </entity type> <context> Interest paid in cash, including note repurchase premiums, for the years ended December 31, 2024, 2023 and 2022 was $ 344 million, $ 301 million and $ 234 million, respectively. Cash interest for the years ended December 31, 2024, 2023 and 2022 included $ 0 , $ 3 million and $ 17 million of note repurchase premiums, respectively. </context> | us-gaap:InterestPaidNet |
Interest paid in cash, including note repurchase premiums, for the years ended December 31, 2024, 2023 and 2022 was $ 344 million, $ 301 million and $ 234 million, respectively. Cash interest for the years ended December 31, 2024, 2023 and 2022 included $ 0 , $ 3 million and $ 17 million of note repurchase premiums, respectively. | text | 301 | monetaryItemType | text: <entity> 301 </entity> <entity type> monetaryItemType </entity type> <context> Interest paid in cash, including note repurchase premiums, for the years ended December 31, 2024, 2023 and 2022 was $ 344 million, $ 301 million and $ 234 million, respectively. Cash interest for the years ended December 31, 2024, 2023 and 2022 included $ 0 , $ 3 million and $ 17 million of note repurchase premiums, respectively. </context> | us-gaap:InterestPaidNet |
Interest paid in cash, including note repurchase premiums, for the years ended December 31, 2024, 2023 and 2022 was $ 344 million, $ 301 million and $ 234 million, respectively. Cash interest for the years ended December 31, 2024, 2023 and 2022 included $ 0 , $ 3 million and $ 17 million of note repurchase premiums, respectively. | text | 234 | monetaryItemType | text: <entity> 234 </entity> <entity type> monetaryItemType </entity type> <context> Interest paid in cash, including note repurchase premiums, for the years ended December 31, 2024, 2023 and 2022 was $ 344 million, $ 301 million and $ 234 million, respectively. Cash interest for the years ended December 31, 2024, 2023 and 2022 included $ 0 , $ 3 million and $ 17 million of note repurchase premiums, respectively. </context> | us-gaap:InterestPaidNet |
For the year ended December 31, 2024, the Company recorded a pretax gain of approximately $ 6 million on the sale of the land and buildings of previously closed plants in the Americas. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2024, the Company recorded a pretax gain of approximately $ 6 million on the sale of the land and buildings of previously closed plants in the Americas. </context> | us-gaap:GainLossOnSaleOfOtherAssets |
For the year ended December 31, 2023, the Company recorded a pretax gain of approximately $ 4 million on the sale of the land and buildings of a previously closed plant in China. | text | 4 | monetaryItemType | text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2023, the Company recorded a pretax gain of approximately $ 4 million on the sale of the land and buildings of a previously closed plant in China. </context> | us-gaap:GainLossOnSaleOfOtherAssets |
For the year ended December 31, 2022, the Company recorded pretax gains of approximately $ 334 million on the sale of land and buildings of two of its plants in the Americas and a pretax gain of $ 55 million related to the sale of the Company’s glass tableware business in Colombia. Additional details of these transactions are described below. | text | 334 | monetaryItemType | text: <entity> 334 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2022, the Company recorded pretax gains of approximately $ 334 million on the sale of land and buildings of two of its plants in the Americas and a pretax gain of $ 55 million related to the sale of the Company’s glass tableware business in Colombia. Additional details of these transactions are described below. </context> | us-gaap:SaleAndLeasebackTransactionGainLossNet |
For the year ended December 31, 2022, the Company recorded pretax gains of approximately $ 334 million on the sale of land and buildings of two of its plants in the Americas and a pretax gain of $ 55 million related to the sale of the Company’s glass tableware business in Colombia. Additional details of these transactions are described below. | text | 55 | monetaryItemType | text: <entity> 55 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2022, the Company recorded pretax gains of approximately $ 334 million on the sale of land and buildings of two of its plants in the Americas and a pretax gain of $ 55 million related to the sale of the Company’s glass tableware business in Colombia. Additional details of these transactions are described below. </context> | us-gaap:GainLossOnSaleOfOtherAssets |
In August 2022, the Company completed the sale of the land and building related to its Vernon, California (Los Angeles) plant to 2900 Fruitland Avenue Investors LLC and 2901 Fruitland Avenue Investors LLC (“Fruitland”). Proceeds from the sale were approximately $ 181 million and the Company recorded a pretax gain of approximately $ 153 million (approximately $ 153 million after tax) on the sale, which is reflected in Other income (expense), net in the Consolidated Results of Operations. | text | 181 | monetaryItemType | text: <entity> 181 </entity> <entity type> monetaryItemType </entity type> <context> In August 2022, the Company completed the sale of the land and building related to its Vernon, California (Los Angeles) plant to 2900 Fruitland Avenue Investors LLC and 2901 Fruitland Avenue Investors LLC (“Fruitland”). Proceeds from the sale were approximately $ 181 million and the Company recorded a pretax gain of approximately $ 153 million (approximately $ 153 million after tax) on the sale, which is reflected in Other income (expense), net in the Consolidated Results of Operations. </context> | us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested |
In August 2022, the Company completed the sale of the land and building related to its Vernon, California (Los Angeles) plant to 2900 Fruitland Avenue Investors LLC and 2901 Fruitland Avenue Investors LLC (“Fruitland”). Proceeds from the sale were approximately $ 181 million and the Company recorded a pretax gain of approximately $ 153 million (approximately $ 153 million after tax) on the sale, which is reflected in Other income (expense), net in the Consolidated Results of Operations. | text | 153 | monetaryItemType | text: <entity> 153 </entity> <entity type> monetaryItemType </entity type> <context> In August 2022, the Company completed the sale of the land and building related to its Vernon, California (Los Angeles) plant to 2900 Fruitland Avenue Investors LLC and 2901 Fruitland Avenue Investors LLC (“Fruitland”). Proceeds from the sale were approximately $ 181 million and the Company recorded a pretax gain of approximately $ 153 million (approximately $ 153 million after tax) on the sale, which is reflected in Other income (expense), net in the Consolidated Results of Operations. </context> | us-gaap:SaleAndLeasebackTransactionGainLossNet |
In May 2022, the Company completed the sale of the land and building related to its Brampton, Ontario, Canada plant to an affiliate of Crestpoint Real Estate Investments Ltd. (“Crestpoint”). Net proceeds were approximately $ 190 million, and the Company recorded a pretax gain of approximately $ 181 million (approximately $ 158 million after tax) on the sale, which is reflected in Other income (expense), net in the Consolidated Results of Operations. | text | 190 | monetaryItemType | text: <entity> 190 </entity> <entity type> monetaryItemType </entity type> <context> In May 2022, the Company completed the sale of the land and building related to its Brampton, Ontario, Canada plant to an affiliate of Crestpoint Real Estate Investments Ltd. (“Crestpoint”). Net proceeds were approximately $ 190 million, and the Company recorded a pretax gain of approximately $ 181 million (approximately $ 158 million after tax) on the sale, which is reflected in Other income (expense), net in the Consolidated Results of Operations. </context> | us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested |
In May 2022, the Company completed the sale of the land and building related to its Brampton, Ontario, Canada plant to an affiliate of Crestpoint Real Estate Investments Ltd. (“Crestpoint”). Net proceeds were approximately $ 190 million, and the Company recorded a pretax gain of approximately $ 181 million (approximately $ 158 million after tax) on the sale, which is reflected in Other income (expense), net in the Consolidated Results of Operations. | text | 181 | monetaryItemType | text: <entity> 181 </entity> <entity type> monetaryItemType </entity type> <context> In May 2022, the Company completed the sale of the land and building related to its Brampton, Ontario, Canada plant to an affiliate of Crestpoint Real Estate Investments Ltd. (“Crestpoint”). Net proceeds were approximately $ 190 million, and the Company recorded a pretax gain of approximately $ 181 million (approximately $ 158 million after tax) on the sale, which is reflected in Other income (expense), net in the Consolidated Results of Operations. </context> | us-gaap:SaleAndLeasebackTransactionGainLossNet |
In March 2022, the Company completed the sale of its Cristar TableTop S.A.S. business to Vidros Colombia S.A.S, an affiliate of Nadir Figueiredo S.A., a glass tableware producer based in Brazil. Gross proceeds received were approximately $ 96 million and the related pretax gain recorded was approximately $ 55 million (approximately $ 16 million after tax and noncontrolling interest) in the first quarter of 2022. The pretax gain was recorded to Other income (expense), net in the Consolidated Results of Operations. | text | 96 | monetaryItemType | text: <entity> 96 </entity> <entity type> monetaryItemType </entity type> <context> In March 2022, the Company completed the sale of its Cristar TableTop S.A.S. business to Vidros Colombia S.A.S, an affiliate of Nadir Figueiredo S.A., a glass tableware producer based in Brazil. Gross proceeds received were approximately $ 96 million and the related pretax gain recorded was approximately $ 55 million (approximately $ 16 million after tax and noncontrolling interest) in the first quarter of 2022. The pretax gain was recorded to Other income (expense), net in the Consolidated Results of Operations. </context> | us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested |
In August 2022, we completed a follow-on offering that included our offer and sale of 1,150,000 shares of common stock at a public offering price of $ 215.00 per share. We received net proceeds of $ 243.8 million after deducting underwriting discounts, commissions, and offering expenses. | text | 1150000 | sharesItemType | text: <entity> 1150000 </entity> <entity type> sharesItemType </entity type> <context> In August 2022, we completed a follow-on offering that included our offer and sale of 1,150,000 shares of common stock at a public offering price of $ 215.00 per share. We received net proceeds of $ 243.8 million after deducting underwriting discounts, commissions, and offering expenses. </context> | us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction |
In August 2022, we completed a follow-on offering that included our offer and sale of 1,150,000 shares of common stock at a public offering price of $ 215.00 per share. We received net proceeds of $ 243.8 million after deducting underwriting discounts, commissions, and offering expenses. | text | 215.00 | perShareItemType | text: <entity> 215.00 </entity> <entity type> perShareItemType </entity type> <context> In August 2022, we completed a follow-on offering that included our offer and sale of 1,150,000 shares of common stock at a public offering price of $ 215.00 per share. We received net proceeds of $ 243.8 million after deducting underwriting discounts, commissions, and offering expenses. </context> | us-gaap:SaleOfStockPricePerShare |
In August 2022, we completed a follow-on offering that included our offer and sale of 1,150,000 shares of common stock at a public offering price of $ 215.00 per share. We received net proceeds of $ 243.8 million after deducting underwriting discounts, commissions, and offering expenses. | text | 243.8 | monetaryItemType | text: <entity> 243.8 </entity> <entity type> monetaryItemType </entity type> <context> In August 2022, we completed a follow-on offering that included our offer and sale of 1,150,000 shares of common stock at a public offering price of $ 215.00 per share. We received net proceeds of $ 243.8 million after deducting underwriting discounts, commissions, and offering expenses. </context> | us-gaap:SaleOfStockConsiderationReceivedOnTransaction |
Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Sales and expenses denominated in foreign currencies are translated at exchange rates in effect on the date of the transaction. Foreign currency transaction gains and losses and the impacts of foreign currency remeasurement are recognized in other expense, net in the consolidated statements of operations and comprehensive income (loss). For the years ended December 31, 2024, 2023, and 2022, we recognized a total of $ 0.9 million, $ 0.2 million, and $ 0.1 million of losses, net, respectively. Any unrealized gains and losses due to translation adjustments are included in accumulated other comprehensive income within stockholders' equity in the consolidated balance sheets. We had $ 0.2 million of unrecognized gain in our accumulated other comprehensive income balance as of both December 31, 2024 and 2023. | text | 0.9 | monetaryItemType | text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Sales and expenses denominated in foreign currencies are translated at exchange rates in effect on the date of the transaction. Foreign currency transaction gains and losses and the impacts of foreign currency remeasurement are recognized in other expense, net in the consolidated statements of operations and comprehensive income (loss). For the years ended December 31, 2024, 2023, and 2022, we recognized a total of $ 0.9 million, $ 0.2 million, and $ 0.1 million of losses, net, respectively. Any unrealized gains and losses due to translation adjustments are included in accumulated other comprehensive income within stockholders' equity in the consolidated balance sheets. We had $ 0.2 million of unrecognized gain in our accumulated other comprehensive income balance as of both December 31, 2024 and 2023. </context> | us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax |
Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Sales and expenses denominated in foreign currencies are translated at exchange rates in effect on the date of the transaction. Foreign currency transaction gains and losses and the impacts of foreign currency remeasurement are recognized in other expense, net in the consolidated statements of operations and comprehensive income (loss). For the years ended December 31, 2024, 2023, and 2022, we recognized a total of $ 0.9 million, $ 0.2 million, and $ 0.1 million of losses, net, respectively. Any unrealized gains and losses due to translation adjustments are included in accumulated other comprehensive income within stockholders' equity in the consolidated balance sheets. We had $ 0.2 million of unrecognized gain in our accumulated other comprehensive income balance as of both December 31, 2024 and 2023. | text | 0.2 | monetaryItemType | text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Sales and expenses denominated in foreign currencies are translated at exchange rates in effect on the date of the transaction. Foreign currency transaction gains and losses and the impacts of foreign currency remeasurement are recognized in other expense, net in the consolidated statements of operations and comprehensive income (loss). For the years ended December 31, 2024, 2023, and 2022, we recognized a total of $ 0.9 million, $ 0.2 million, and $ 0.1 million of losses, net, respectively. Any unrealized gains and losses due to translation adjustments are included in accumulated other comprehensive income within stockholders' equity in the consolidated balance sheets. We had $ 0.2 million of unrecognized gain in our accumulated other comprehensive income balance as of both December 31, 2024 and 2023. </context> | us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax |
Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Sales and expenses denominated in foreign currencies are translated at exchange rates in effect on the date of the transaction. Foreign currency transaction gains and losses and the impacts of foreign currency remeasurement are recognized in other expense, net in the consolidated statements of operations and comprehensive income (loss). For the years ended December 31, 2024, 2023, and 2022, we recognized a total of $ 0.9 million, $ 0.2 million, and $ 0.1 million of losses, net, respectively. Any unrealized gains and losses due to translation adjustments are included in accumulated other comprehensive income within stockholders' equity in the consolidated balance sheets. We had $ 0.2 million of unrecognized gain in our accumulated other comprehensive income balance as of both December 31, 2024 and 2023. | text | 0.1 | monetaryItemType | text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Sales and expenses denominated in foreign currencies are translated at exchange rates in effect on the date of the transaction. Foreign currency transaction gains and losses and the impacts of foreign currency remeasurement are recognized in other expense, net in the consolidated statements of operations and comprehensive income (loss). For the years ended December 31, 2024, 2023, and 2022, we recognized a total of $ 0.9 million, $ 0.2 million, and $ 0.1 million of losses, net, respectively. Any unrealized gains and losses due to translation adjustments are included in accumulated other comprehensive income within stockholders' equity in the consolidated balance sheets. We had $ 0.2 million of unrecognized gain in our accumulated other comprehensive income balance as of both December 31, 2024 and 2023. </context> | us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax |
There were no investments in an unrealized loss position at December 31, 2023. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> There were no investments in an unrealized loss position at December 31, 2023. </context> | us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition |
Investments are classified as available-for-sale and are reported at their estimated fair market values which are based on quoted, active or inactive market prices when available. Any unrealized gains and losses due to interest rate fluctuations and other external factors are reported as a separate component of accumulated other comprehensive income within stockholders' equity. We had $ 0.4 million and $ 0.6 million of unrecognized gains in our accumulated other comprehensive income balance at December 31, 2024 and 2023, respectively. Any realized gains and losses are calculated on the specific identification method and reported net in other expense, net in the consolidated statements of operations and comprehensive income (loss). We recorded $ 0 of gross realized gains from the sale or maturity of available-for-sale investments during each of the years ended December 31, 2024, 2023, and 2022. We recorded $ 0 of gross realized losses from the sale or maturity of available-for-sale investments during each of the years ended December 31, 2024, 2023, and 2022. | text | 0.4 | monetaryItemType | text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> Investments are classified as available-for-sale and are reported at their estimated fair market values which are based on quoted, active or inactive market prices when available. Any unrealized gains and losses due to interest rate fluctuations and other external factors are reported as a separate component of accumulated other comprehensive income within stockholders' equity. We had $ 0.4 million and $ 0.6 million of unrecognized gains in our accumulated other comprehensive income balance at December 31, 2024 and 2023, respectively. Any realized gains and losses are calculated on the specific identification method and reported net in other expense, net in the consolidated statements of operations and comprehensive income (loss). We recorded $ 0 of gross realized gains from the sale or maturity of available-for-sale investments during each of the years ended December 31, 2024, 2023, and 2022. We recorded $ 0 of gross realized losses from the sale or maturity of available-for-sale investments during each of the years ended December 31, 2024, 2023, and 2022. </context> | us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax |
Investments are classified as available-for-sale and are reported at their estimated fair market values which are based on quoted, active or inactive market prices when available. Any unrealized gains and losses due to interest rate fluctuations and other external factors are reported as a separate component of accumulated other comprehensive income within stockholders' equity. We had $ 0.4 million and $ 0.6 million of unrecognized gains in our accumulated other comprehensive income balance at December 31, 2024 and 2023, respectively. Any realized gains and losses are calculated on the specific identification method and reported net in other expense, net in the consolidated statements of operations and comprehensive income (loss). We recorded $ 0 of gross realized gains from the sale or maturity of available-for-sale investments during each of the years ended December 31, 2024, 2023, and 2022. We recorded $ 0 of gross realized losses from the sale or maturity of available-for-sale investments during each of the years ended December 31, 2024, 2023, and 2022. | text | 0.6 | monetaryItemType | text: <entity> 0.6 </entity> <entity type> monetaryItemType </entity type> <context> Investments are classified as available-for-sale and are reported at their estimated fair market values which are based on quoted, active or inactive market prices when available. Any unrealized gains and losses due to interest rate fluctuations and other external factors are reported as a separate component of accumulated other comprehensive income within stockholders' equity. We had $ 0.4 million and $ 0.6 million of unrecognized gains in our accumulated other comprehensive income balance at December 31, 2024 and 2023, respectively. Any realized gains and losses are calculated on the specific identification method and reported net in other expense, net in the consolidated statements of operations and comprehensive income (loss). We recorded $ 0 of gross realized gains from the sale or maturity of available-for-sale investments during each of the years ended December 31, 2024, 2023, and 2022. We recorded $ 0 of gross realized losses from the sale or maturity of available-for-sale investments during each of the years ended December 31, 2024, 2023, and 2022. </context> | us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax |
We regularly review inventory quantities on-hand for excess and obsolete inventory and, when circumstances indicate, incur charges to write down inventories to their net realizable value. The determination of a reserve for excess and obsolete inventory involves management exercising judgment to determine the required reserve, considering future demand, product life cycles, introduction of new products, and current market conditions. The reserve for excess and obsolete inventory was $ 1.0 million and $ 2.4 million as of December 31, 2024 and 2023, respectively. | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> We regularly review inventory quantities on-hand for excess and obsolete inventory and, when circumstances indicate, incur charges to write down inventories to their net realizable value. The determination of a reserve for excess and obsolete inventory involves management exercising judgment to determine the required reserve, considering future demand, product life cycles, introduction of new products, and current market conditions. The reserve for excess and obsolete inventory was $ 1.0 million and $ 2.4 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:InventoryValuationReserves |
We regularly review inventory quantities on-hand for excess and obsolete inventory and, when circumstances indicate, incur charges to write down inventories to their net realizable value. The determination of a reserve for excess and obsolete inventory involves management exercising judgment to determine the required reserve, considering future demand, product life cycles, introduction of new products, and current market conditions. The reserve for excess and obsolete inventory was $ 1.0 million and $ 2.4 million as of December 31, 2024 and 2023, respectively. | text | 2.4 | monetaryItemType | text: <entity> 2.4 </entity> <entity type> monetaryItemType </entity type> <context> We regularly review inventory quantities on-hand for excess and obsolete inventory and, when circumstances indicate, incur charges to write down inventories to their net realizable value. The determination of a reserve for excess and obsolete inventory involves management exercising judgment to determine the required reserve, considering future demand, product life cycles, introduction of new products, and current market conditions. The reserve for excess and obsolete inventory was $ 1.0 million and $ 2.4 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:InventoryValuationReserves |
Internal-use software costs are capitalized during the application development stage. Costs related to planning and post implementation activities are expensed as incurred. Capitalized internal-use software is amortized, and recognized as cost of goods sold or selling, general and administrative expenses, on a straight-line basis over the estimated useful life of three years . Construction in process is comprised primarily of manufacturing equipment. Depreciation is determined using the straight-line method over the estimated useful lives of the respective assets, generally three to ten years . Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the term of the lease. Depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million during the years ended December 31, 2024, 2023, and 2022, respectively. | text | 6.6 | monetaryItemType | text: <entity> 6.6 </entity> <entity type> monetaryItemType </entity type> <context> Internal-use software costs are capitalized during the application development stage. Costs related to planning and post implementation activities are expensed as incurred. Capitalized internal-use software is amortized, and recognized as cost of goods sold or selling, general and administrative expenses, on a straight-line basis over the estimated useful life of three years . Construction in process is comprised primarily of manufacturing equipment. Depreciation is determined using the straight-line method over the estimated useful lives of the respective assets, generally three to ten years . Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the term of the lease. Depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million during the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DepreciationAndAmortization |
Internal-use software costs are capitalized during the application development stage. Costs related to planning and post implementation activities are expensed as incurred. Capitalized internal-use software is amortized, and recognized as cost of goods sold or selling, general and administrative expenses, on a straight-line basis over the estimated useful life of three years . Construction in process is comprised primarily of manufacturing equipment. Depreciation is determined using the straight-line method over the estimated useful lives of the respective assets, generally three to ten years . Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the term of the lease. Depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million during the years ended December 31, 2024, 2023, and 2022, respectively. | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> Internal-use software costs are capitalized during the application development stage. Costs related to planning and post implementation activities are expensed as incurred. Capitalized internal-use software is amortized, and recognized as cost of goods sold or selling, general and administrative expenses, on a straight-line basis over the estimated useful life of three years . Construction in process is comprised primarily of manufacturing equipment. Depreciation is determined using the straight-line method over the estimated useful lives of the respective assets, generally three to ten years . Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the term of the lease. Depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million during the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DepreciationAndAmortization |
Internal-use software costs are capitalized during the application development stage. Costs related to planning and post implementation activities are expensed as incurred. Capitalized internal-use software is amortized, and recognized as cost of goods sold or selling, general and administrative expenses, on a straight-line basis over the estimated useful life of three years . Construction in process is comprised primarily of manufacturing equipment. Depreciation is determined using the straight-line method over the estimated useful lives of the respective assets, generally three to ten years . Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the term of the lease. Depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million during the years ended December 31, 2024, 2023, and 2022, respectively. | text | 1.9 | monetaryItemType | text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> Internal-use software costs are capitalized during the application development stage. Costs related to planning and post implementation activities are expensed as incurred. Capitalized internal-use software is amortized, and recognized as cost of goods sold or selling, general and administrative expenses, on a straight-line basis over the estimated useful life of three years . Construction in process is comprised primarily of manufacturing equipment. Depreciation is determined using the straight-line method over the estimated useful lives of the respective assets, generally three to ten years . Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the term of the lease. Depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million during the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DepreciationAndAmortization |
For equity securities without readily determinable fair values, we have elected the measurement alternative under which we measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These securities are presented within other non-current assets on the consolidated balance sheets. The balance of equity securities without readily determinable fair values was $ 10.6 million and $ 10.4 million as of December 31, 2024 and 2023, respectively. We recognized an impairment charge of $ 0.4 million during the year ended December 31, 2023 due to a deterioration in the performance and quality of one of the equity securities that had an original carrying amount of $ 0.8 million. There was no adjustment to the carrying amounts during the year ended December 31, 2024. | text | 10.6 | monetaryItemType | text: <entity> 10.6 </entity> <entity type> monetaryItemType </entity type> <context> For equity securities without readily determinable fair values, we have elected the measurement alternative under which we measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These securities are presented within other non-current assets on the consolidated balance sheets. The balance of equity securities without readily determinable fair values was $ 10.6 million and $ 10.4 million as of December 31, 2024 and 2023, respectively. We recognized an impairment charge of $ 0.4 million during the year ended December 31, 2023 due to a deterioration in the performance and quality of one of the equity securities that had an original carrying amount of $ 0.8 million. There was no adjustment to the carrying amounts during the year ended December 31, 2024. </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount |
For equity securities without readily determinable fair values, we have elected the measurement alternative under which we measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These securities are presented within other non-current assets on the consolidated balance sheets. The balance of equity securities without readily determinable fair values was $ 10.6 million and $ 10.4 million as of December 31, 2024 and 2023, respectively. We recognized an impairment charge of $ 0.4 million during the year ended December 31, 2023 due to a deterioration in the performance and quality of one of the equity securities that had an original carrying amount of $ 0.8 million. There was no adjustment to the carrying amounts during the year ended December 31, 2024. | text | 10.4 | monetaryItemType | text: <entity> 10.4 </entity> <entity type> monetaryItemType </entity type> <context> For equity securities without readily determinable fair values, we have elected the measurement alternative under which we measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These securities are presented within other non-current assets on the consolidated balance sheets. The balance of equity securities without readily determinable fair values was $ 10.6 million and $ 10.4 million as of December 31, 2024 and 2023, respectively. We recognized an impairment charge of $ 0.4 million during the year ended December 31, 2023 due to a deterioration in the performance and quality of one of the equity securities that had an original carrying amount of $ 0.8 million. There was no adjustment to the carrying amounts during the year ended December 31, 2024. </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount |
For equity securities without readily determinable fair values, we have elected the measurement alternative under which we measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These securities are presented within other non-current assets on the consolidated balance sheets. The balance of equity securities without readily determinable fair values was $ 10.6 million and $ 10.4 million as of December 31, 2024 and 2023, respectively. We recognized an impairment charge of $ 0.4 million during the year ended December 31, 2023 due to a deterioration in the performance and quality of one of the equity securities that had an original carrying amount of $ 0.8 million. There was no adjustment to the carrying amounts during the year ended December 31, 2024. | text | 0.4 | monetaryItemType | text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> For equity securities without readily determinable fair values, we have elected the measurement alternative under which we measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These securities are presented within other non-current assets on the consolidated balance sheets. The balance of equity securities without readily determinable fair values was $ 10.6 million and $ 10.4 million as of December 31, 2024 and 2023, respectively. We recognized an impairment charge of $ 0.4 million during the year ended December 31, 2023 due to a deterioration in the performance and quality of one of the equity securities that had an original carrying amount of $ 0.8 million. There was no adjustment to the carrying amounts during the year ended December 31, 2024. </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount |
For equity securities without readily determinable fair values, we have elected the measurement alternative under which we measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These securities are presented within other non-current assets on the consolidated balance sheets. The balance of equity securities without readily determinable fair values was $ 10.6 million and $ 10.4 million as of December 31, 2024 and 2023, respectively. We recognized an impairment charge of $ 0.4 million during the year ended December 31, 2023 due to a deterioration in the performance and quality of one of the equity securities that had an original carrying amount of $ 0.8 million. There was no adjustment to the carrying amounts during the year ended December 31, 2024. | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> For equity securities without readily determinable fair values, we have elected the measurement alternative under which we measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These securities are presented within other non-current assets on the consolidated balance sheets. The balance of equity securities without readily determinable fair values was $ 10.6 million and $ 10.4 million as of December 31, 2024 and 2023, respectively. We recognized an impairment charge of $ 0.4 million during the year ended December 31, 2023 due to a deterioration in the performance and quality of one of the equity securities that had an original carrying amount of $ 0.8 million. There was no adjustment to the carrying amounts during the year ended December 31, 2024. </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount |
For equity securities without readily determinable fair values, we have elected the measurement alternative under which we measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These securities are presented within other non-current assets on the consolidated balance sheets. The balance of equity securities without readily determinable fair values was $ 10.6 million and $ 10.4 million as of December 31, 2024 and 2023, respectively. We recognized an impairment charge of $ 0.4 million during the year ended December 31, 2023 due to a deterioration in the performance and quality of one of the equity securities that had an original carrying amount of $ 0.8 million. There was no adjustment to the carrying amounts during the year ended December 31, 2024. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> For equity securities without readily determinable fair values, we have elected the measurement alternative under which we measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These securities are presented within other non-current assets on the consolidated balance sheets. The balance of equity securities without readily determinable fair values was $ 10.6 million and $ 10.4 million as of December 31, 2024 and 2023, respectively. We recognized an impairment charge of $ 0.4 million during the year ended December 31, 2023 due to a deterioration in the performance and quality of one of the equity securities that had an original carrying amount of $ 0.8 million. There was no adjustment to the carrying amounts during the year ended December 31, 2024. </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount |
Long-lived assets consist primarily of property and equipment, operating lease right-of-use assets, and strategic investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require that an asset be tested for possible impairment, we compare the undiscounted cash flows expected to be generated by the asset to the carrying amount of the asset. If the carrying amount of the asset is not recoverable on an undiscounted cash flow basis, we determine the fair value of the asset and recognize an impairment loss to the extent the carrying amount of the asset exceeds its fair value. We determine fair value using the income approach based on the present value of expected future cash flows or other appropriate measures of estimated fair value. Our cash flow assumptions consider historical and forecasted revenue and operating costs and other relevant factors. We did not record any impairment charges on long-lived assets, other than the $ 0.4 million discussed above in the | text | 0.4 | monetaryItemType | text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> Long-lived assets consist primarily of property and equipment, operating lease right-of-use assets, and strategic investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require that an asset be tested for possible impairment, we compare the undiscounted cash flows expected to be generated by the asset to the carrying amount of the asset. If the carrying amount of the asset is not recoverable on an undiscounted cash flow basis, we determine the fair value of the asset and recognize an impairment loss to the extent the carrying amount of the asset exceeds its fair value. We determine fair value using the income approach based on the present value of expected future cash flows or other appropriate measures of estimated fair value. Our cash flow assumptions consider historical and forecasted revenue and operating costs and other relevant factors. We did not record any impairment charges on long-lived assets, other than the $ 0.4 million discussed above in the </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount |
We expense the costs of advertising, including promotional expenses, as incurred. Advertising expenses were $ 94.9 million, $ 100.3 million, and $ 74.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. | text | 94.9 | monetaryItemType | text: <entity> 94.9 </entity> <entity type> monetaryItemType </entity type> <context> We expense the costs of advertising, including promotional expenses, as incurred. Advertising expenses were $ 94.9 million, $ 100.3 million, and $ 74.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
We expense the costs of advertising, including promotional expenses, as incurred. Advertising expenses were $ 94.9 million, $ 100.3 million, and $ 74.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. | text | 100.3 | monetaryItemType | text: <entity> 100.3 </entity> <entity type> monetaryItemType </entity type> <context> We expense the costs of advertising, including promotional expenses, as incurred. Advertising expenses were $ 94.9 million, $ 100.3 million, and $ 74.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
We expense the costs of advertising, including promotional expenses, as incurred. Advertising expenses were $ 94.9 million, $ 100.3 million, and $ 74.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. | text | 74.3 | monetaryItemType | text: <entity> 74.3 </entity> <entity type> monetaryItemType </entity type> <context> We expense the costs of advertising, including promotional expenses, as incurred. Advertising expenses were $ 94.9 million, $ 100.3 million, and $ 74.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
We had purchase commitments to suppliers for purchases totaling $ 86.0 million as of December 31, 2024. | text | 86.0 | monetaryItemType | text: <entity> 86.0 </entity> <entity type> monetaryItemType </entity type> <context> We had purchase commitments to suppliers for purchases totaling $ 86.0 million as of December 31, 2024. </context> | us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted |
As of December 31, 2024, the remaining lease terms were 10.4 years and the weighted average discount rate was 4.9 %. The operating cash (inflow) outflows from our operating leases were $( 3.3 ) million, $ 2.2 million, and $ 0.7 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 4.9 | percentItemType | text: <entity> 4.9 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2024, the remaining lease terms were 10.4 years and the weighted average discount rate was 4.9 %. The operating cash (inflow) outflows from our operating leases were $( 3.3 ) million, $ 2.2 million, and $ 0.7 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:LesseeOperatingLeaseDiscountRate |
In March 2019, we amended our $ 24.5 million loan and security agreement, which we refer to as our former credit facility. The debt was interest only until April 1, 2022 and was scheduled to mature on March 1, 2024. The basic interest rate was the 30-day U.S. LIBOR rate, subject to a floor of 7.60 %. In addition to the principal and interest payments, we were required to pay a final payment fee of 3.50 % on all amounts outstanding, which was being accreted using the effective interest rate method over the term of the credit facility and was to be due at the earlier of maturity or prepayment. Borrowings were prepayable in whole at our option, subject to a prepayment fee of 1.00 %. | text | 24.5 | monetaryItemType | text: <entity> 24.5 </entity> <entity type> monetaryItemType </entity type> <context> In March 2019, we amended our $ 24.5 million loan and security agreement, which we refer to as our former credit facility. The debt was interest only until April 1, 2022 and was scheduled to mature on March 1, 2024. The basic interest rate was the 30-day U.S. LIBOR rate, subject to a floor of 7.60 %. In addition to the principal and interest payments, we were required to pay a final payment fee of 3.50 % on all amounts outstanding, which was being accreted using the effective interest rate method over the term of the credit facility and was to be due at the earlier of maturity or prepayment. Borrowings were prepayable in whole at our option, subject to a prepayment fee of 1.00 %. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
In March 2019, we amended our $ 24.5 million loan and security agreement, which we refer to as our former credit facility. The debt was interest only until April 1, 2022 and was scheduled to mature on March 1, 2024. The basic interest rate was the 30-day U.S. LIBOR rate, subject to a floor of 7.60 %. In addition to the principal and interest payments, we were required to pay a final payment fee of 3.50 % on all amounts outstanding, which was being accreted using the effective interest rate method over the term of the credit facility and was to be due at the earlier of maturity or prepayment. Borrowings were prepayable in whole at our option, subject to a prepayment fee of 1.00 %. | text | 7.60 | percentItemType | text: <entity> 7.60 </entity> <entity type> percentItemType </entity type> <context> In March 2019, we amended our $ 24.5 million loan and security agreement, which we refer to as our former credit facility. The debt was interest only until April 1, 2022 and was scheduled to mature on March 1, 2024. The basic interest rate was the 30-day U.S. LIBOR rate, subject to a floor of 7.60 %. In addition to the principal and interest payments, we were required to pay a final payment fee of 3.50 % on all amounts outstanding, which was being accreted using the effective interest rate method over the term of the credit facility and was to be due at the earlier of maturity or prepayment. Borrowings were prepayable in whole at our option, subject to a prepayment fee of 1.00 %. </context> | us-gaap:DebtInstrumentInterestRateDuringPeriod |
In August 2022, we prepaid the outstanding principal balance of $ 19.4 million, the final payment fee of $ 0.9 million, and the prepayment fee of $ 0.2 million. We had no remaining amounts outstanding under our former credit facility as of either December 31, 2024 or 2023. | text | 19.4 | monetaryItemType | text: <entity> 19.4 </entity> <entity type> monetaryItemType </entity type> <context> In August 2022, we prepaid the outstanding principal balance of $ 19.4 million, the final payment fee of $ 0.9 million, and the prepayment fee of $ 0.2 million. We had no remaining amounts outstanding under our former credit facility as of either December 31, 2024 or 2023. </context> | us-gaap:ExtinguishmentOfDebtAmount |
In August 2022, we prepaid the outstanding principal balance of $ 19.4 million, the final payment fee of $ 0.9 million, and the prepayment fee of $ 0.2 million. We had no remaining amounts outstanding under our former credit facility as of either December 31, 2024 or 2023. | text | 0.2 | monetaryItemType | text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> In August 2022, we prepaid the outstanding principal balance of $ 19.4 million, the final payment fee of $ 0.9 million, and the prepayment fee of $ 0.2 million. We had no remaining amounts outstanding under our former credit facility as of either December 31, 2024 or 2023. </context> | us-gaap:PaymentsOfDebtExtinguishmentCosts |
We sponsor a defined contribution employee retirement plan covering all of our full-time employees. The plan allows eligible employees to defer a portion of their eligible compensation up to the maximum allowed by IRS Regulations. We make voluntary matching contributions of 50 % of the first 6 % of each participating employee's contribution, up to 3 % of eligible earnings. Our match contributions are made to funds designated by the participant, none of which are based on Inspire common stock, and totaled $ 4.7 million, $ 3.7 million, and $ 2.4 million | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> We sponsor a defined contribution employee retirement plan covering all of our full-time employees. The plan allows eligible employees to defer a portion of their eligible compensation up to the maximum allowed by IRS Regulations. We make voluntary matching contributions of 50 % of the first 6 % of each participating employee's contribution, up to 3 % of eligible earnings. Our match contributions are made to funds designated by the participant, none of which are based on Inspire common stock, and totaled $ 4.7 million, $ 3.7 million, and $ 2.4 million </context> | us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch |
We sponsor a defined contribution employee retirement plan covering all of our full-time employees. The plan allows eligible employees to defer a portion of their eligible compensation up to the maximum allowed by IRS Regulations. We make voluntary matching contributions of 50 % of the first 6 % of each participating employee's contribution, up to 3 % of eligible earnings. Our match contributions are made to funds designated by the participant, none of which are based on Inspire common stock, and totaled $ 4.7 million, $ 3.7 million, and $ 2.4 million | text | 3 | percentItemType | text: <entity> 3 </entity> <entity type> percentItemType </entity type> <context> We sponsor a defined contribution employee retirement plan covering all of our full-time employees. The plan allows eligible employees to defer a portion of their eligible compensation up to the maximum allowed by IRS Regulations. We make voluntary matching contributions of 50 % of the first 6 % of each participating employee's contribution, up to 3 % of eligible earnings. Our match contributions are made to funds designated by the participant, none of which are based on Inspire common stock, and totaled $ 4.7 million, $ 3.7 million, and $ 2.4 million </context> | us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent |
We sponsor a defined contribution employee retirement plan covering all of our full-time employees. The plan allows eligible employees to defer a portion of their eligible compensation up to the maximum allowed by IRS Regulations. We make voluntary matching contributions of 50 % of the first 6 % of each participating employee's contribution, up to 3 % of eligible earnings. Our match contributions are made to funds designated by the participant, none of which are based on Inspire common stock, and totaled $ 4.7 million, $ 3.7 million, and $ 2.4 million | text | 4.7 | monetaryItemType | text: <entity> 4.7 </entity> <entity type> monetaryItemType </entity type> <context> We sponsor a defined contribution employee retirement plan covering all of our full-time employees. The plan allows eligible employees to defer a portion of their eligible compensation up to the maximum allowed by IRS Regulations. We make voluntary matching contributions of 50 % of the first 6 % of each participating employee's contribution, up to 3 % of eligible earnings. Our match contributions are made to funds designated by the participant, none of which are based on Inspire common stock, and totaled $ 4.7 million, $ 3.7 million, and $ 2.4 million </context> | us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount |
We sponsor a defined contribution employee retirement plan covering all of our full-time employees. The plan allows eligible employees to defer a portion of their eligible compensation up to the maximum allowed by IRS Regulations. We make voluntary matching contributions of 50 % of the first 6 % of each participating employee's contribution, up to 3 % of eligible earnings. Our match contributions are made to funds designated by the participant, none of which are based on Inspire common stock, and totaled $ 4.7 million, $ 3.7 million, and $ 2.4 million | text | 3.7 | monetaryItemType | text: <entity> 3.7 </entity> <entity type> monetaryItemType </entity type> <context> We sponsor a defined contribution employee retirement plan covering all of our full-time employees. The plan allows eligible employees to defer a portion of their eligible compensation up to the maximum allowed by IRS Regulations. We make voluntary matching contributions of 50 % of the first 6 % of each participating employee's contribution, up to 3 % of eligible earnings. Our match contributions are made to funds designated by the participant, none of which are based on Inspire common stock, and totaled $ 4.7 million, $ 3.7 million, and $ 2.4 million </context> | us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount |
We sponsor a defined contribution employee retirement plan covering all of our full-time employees. The plan allows eligible employees to defer a portion of their eligible compensation up to the maximum allowed by IRS Regulations. We make voluntary matching contributions of 50 % of the first 6 % of each participating employee's contribution, up to 3 % of eligible earnings. Our match contributions are made to funds designated by the participant, none of which are based on Inspire common stock, and totaled $ 4.7 million, $ 3.7 million, and $ 2.4 million | text | 2.4 | monetaryItemType | text: <entity> 2.4 </entity> <entity type> monetaryItemType </entity type> <context> We sponsor a defined contribution employee retirement plan covering all of our full-time employees. The plan allows eligible employees to defer a portion of their eligible compensation up to the maximum allowed by IRS Regulations. We make voluntary matching contributions of 50 % of the first 6 % of each participating employee's contribution, up to 3 % of eligible earnings. Our match contributions are made to funds designated by the participant, none of which are based on Inspire common stock, and totaled $ 4.7 million, $ 3.7 million, and $ 2.4 million </context> | us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount |
In November 2024, we entered into an accelerated share repurchase agreement (the “ASR Agreement”) with a large financial institution to repurchase common stock as part of the share repurchase program. Under the ASR Agreement, the financial institution delivered a portion of shares to us at contract inception and delivered the remaining shares at settlement. We made a prepayment of $ 75.0 million and received an initial delivery of 305,157 shares of common stock. We retired the initial shares delivered and recorded a $ 75.0 million reduction to additional paid-in capital. We accounted for the variable component of shares to be delivered under the ASR Agreement as a forward contract indexed to our common stock, which met the criteria for equity classification, and therefore, was accounted for as a component of equity. The ASR Agreement continued to meet the requirements for equity classification as of December 31, 2024. As of December 31, 2024, no excise tax was accrued, as the aggregate fair market value of our stock issuances exceeded the fair market value of stock repurchases during the year. | text | 75.0 | monetaryItemType | text: <entity> 75.0 </entity> <entity type> monetaryItemType </entity type> <context> In November 2024, we entered into an accelerated share repurchase agreement (the “ASR Agreement”) with a large financial institution to repurchase common stock as part of the share repurchase program. Under the ASR Agreement, the financial institution delivered a portion of shares to us at contract inception and delivered the remaining shares at settlement. We made a prepayment of $ 75.0 million and received an initial delivery of 305,157 shares of common stock. We retired the initial shares delivered and recorded a $ 75.0 million reduction to additional paid-in capital. We accounted for the variable component of shares to be delivered under the ASR Agreement as a forward contract indexed to our common stock, which met the criteria for equity classification, and therefore, was accounted for as a component of equity. The ASR Agreement continued to meet the requirements for equity classification as of December 31, 2024. As of December 31, 2024, no excise tax was accrued, as the aggregate fair market value of our stock issuances exceeded the fair market value of stock repurchases during the year. </context> | us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt |
In November 2024, we entered into an accelerated share repurchase agreement (the “ASR Agreement”) with a large financial institution to repurchase common stock as part of the share repurchase program. Under the ASR Agreement, the financial institution delivered a portion of shares to us at contract inception and delivered the remaining shares at settlement. We made a prepayment of $ 75.0 million and received an initial delivery of 305,157 shares of common stock. We retired the initial shares delivered and recorded a $ 75.0 million reduction to additional paid-in capital. We accounted for the variable component of shares to be delivered under the ASR Agreement as a forward contract indexed to our common stock, which met the criteria for equity classification, and therefore, was accounted for as a component of equity. The ASR Agreement continued to meet the requirements for equity classification as of December 31, 2024. As of December 31, 2024, no excise tax was accrued, as the aggregate fair market value of our stock issuances exceeded the fair market value of stock repurchases during the year. | text | 305157 | sharesItemType | text: <entity> 305157 </entity> <entity type> sharesItemType </entity type> <context> In November 2024, we entered into an accelerated share repurchase agreement (the “ASR Agreement”) with a large financial institution to repurchase common stock as part of the share repurchase program. Under the ASR Agreement, the financial institution delivered a portion of shares to us at contract inception and delivered the remaining shares at settlement. We made a prepayment of $ 75.0 million and received an initial delivery of 305,157 shares of common stock. We retired the initial shares delivered and recorded a $ 75.0 million reduction to additional paid-in capital. We accounted for the variable component of shares to be delivered under the ASR Agreement as a forward contract indexed to our common stock, which met the criteria for equity classification, and therefore, was accounted for as a component of equity. The ASR Agreement continued to meet the requirements for equity classification as of December 31, 2024. As of December 31, 2024, no excise tax was accrued, as the aggregate fair market value of our stock issuances exceeded the fair market value of stock repurchases during the year. </context> | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
In November 2024, we entered into an accelerated share repurchase agreement (the “ASR Agreement”) with a large financial institution to repurchase common stock as part of the share repurchase program. Under the ASR Agreement, the financial institution delivered a portion of shares to us at contract inception and delivered the remaining shares at settlement. We made a prepayment of $ 75.0 million and received an initial delivery of 305,157 shares of common stock. We retired the initial shares delivered and recorded a $ 75.0 million reduction to additional paid-in capital. We accounted for the variable component of shares to be delivered under the ASR Agreement as a forward contract indexed to our common stock, which met the criteria for equity classification, and therefore, was accounted for as a component of equity. The ASR Agreement continued to meet the requirements for equity classification as of December 31, 2024. As of December 31, 2024, no excise tax was accrued, as the aggregate fair market value of our stock issuances exceeded the fair market value of stock repurchases during the year. | text | 75.0 | monetaryItemType | text: <entity> 75.0 </entity> <entity type> monetaryItemType </entity type> <context> In November 2024, we entered into an accelerated share repurchase agreement (the “ASR Agreement”) with a large financial institution to repurchase common stock as part of the share repurchase program. Under the ASR Agreement, the financial institution delivered a portion of shares to us at contract inception and delivered the remaining shares at settlement. We made a prepayment of $ 75.0 million and received an initial delivery of 305,157 shares of common stock. We retired the initial shares delivered and recorded a $ 75.0 million reduction to additional paid-in capital. We accounted for the variable component of shares to be delivered under the ASR Agreement as a forward contract indexed to our common stock, which met the criteria for equity classification, and therefore, was accounted for as a component of equity. The ASR Agreement continued to meet the requirements for equity classification as of December 31, 2024. As of December 31, 2024, no excise tax was accrued, as the aggregate fair market value of our stock issuances exceeded the fair market value of stock repurchases during the year. </context> | us-gaap:StockRepurchasedAndRetiredDuringPeriodValue |
In November 2024, we entered into an accelerated share repurchase agreement (the “ASR Agreement”) with a large financial institution to repurchase common stock as part of the share repurchase program. Under the ASR Agreement, the financial institution delivered a portion of shares to us at contract inception and delivered the remaining shares at settlement. We made a prepayment of $ 75.0 million and received an initial delivery of 305,157 shares of common stock. We retired the initial shares delivered and recorded a $ 75.0 million reduction to additional paid-in capital. We accounted for the variable component of shares to be delivered under the ASR Agreement as a forward contract indexed to our common stock, which met the criteria for equity classification, and therefore, was accounted for as a component of equity. The ASR Agreement continued to meet the requirements for equity classification as of December 31, 2024. As of December 31, 2024, no excise tax was accrued, as the aggregate fair market value of our stock issuances exceeded the fair market value of stock repurchases during the year. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> In November 2024, we entered into an accelerated share repurchase agreement (the “ASR Agreement”) with a large financial institution to repurchase common stock as part of the share repurchase program. Under the ASR Agreement, the financial institution delivered a portion of shares to us at contract inception and delivered the remaining shares at settlement. We made a prepayment of $ 75.0 million and received an initial delivery of 305,157 shares of common stock. We retired the initial shares delivered and recorded a $ 75.0 million reduction to additional paid-in capital. We accounted for the variable component of shares to be delivered under the ASR Agreement as a forward contract indexed to our common stock, which met the criteria for equity classification, and therefore, was accounted for as a component of equity. The ASR Agreement continued to meet the requirements for equity classification as of December 31, 2024. As of December 31, 2024, no excise tax was accrued, as the aggregate fair market value of our stock issuances exceeded the fair market value of stock repurchases during the year. </context> | us-gaap:ShareRepurchaseProgramExciseTaxPayable |
In January 2025, we were notified of the early termination of the ASR Agreement. Upon final settlement in January 2025, we received an additional 103,886 shares of common stock from the financial institution. The final number of shares received was based on the volume-weighted average price of our common stock during the term of the ASR Agreement, less a discount and subject to adjustment pursuant to the terms of the ASR Agreement. | text | 103886 | sharesItemType | text: <entity> 103886 </entity> <entity type> sharesItemType </entity type> <context> In January 2025, we were notified of the early termination of the ASR Agreement. Upon final settlement in January 2025, we received an additional 103,886 shares of common stock from the financial institution. The final number of shares received was based on the volume-weighted average price of our common stock during the term of the ASR Agreement, less a discount and subject to adjustment pursuant to the terms of the ASR Agreement. </context> | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
The 305,157 shares of common stock received in November 2024, from the ASR Agreement, are the only shares repurchased during 2024. The total shares repurchased under the ASR Agreement was 409,043 shares with the average share price of $ 190.29 . | text | 305157 | sharesItemType | text: <entity> 305157 </entity> <entity type> sharesItemType </entity type> <context> The 305,157 shares of common stock received in November 2024, from the ASR Agreement, are the only shares repurchased during 2024. The total shares repurchased under the ASR Agreement was 409,043 shares with the average share price of $ 190.29 . </context> | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
The 305,157 shares of common stock received in November 2024, from the ASR Agreement, are the only shares repurchased during 2024. The total shares repurchased under the ASR Agreement was 409,043 shares with the average share price of $ 190.29 . | text | 409043 | sharesItemType | text: <entity> 409043 </entity> <entity type> sharesItemType </entity type> <context> The 305,157 shares of common stock received in November 2024, from the ASR Agreement, are the only shares repurchased during 2024. The total shares repurchased under the ASR Agreement was 409,043 shares with the average share price of $ 190.29 . </context> | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
The 305,157 shares of common stock received in November 2024, from the ASR Agreement, are the only shares repurchased during 2024. The total shares repurchased under the ASR Agreement was 409,043 shares with the average share price of $ 190.29 . | text | 190.29 | perShareItemType | text: <entity> 190.29 </entity> <entity type> perShareItemType </entity type> <context> The 305,157 shares of common stock received in November 2024, from the ASR Agreement, are the only shares repurchased during 2024. The total shares repurchased under the ASR Agreement was 409,043 shares with the average share price of $ 190.29 . </context> | us-gaap:TreasuryStockAcquiredAverageCostPerShare |
As of December 31, 2024, there were 4,521,922 shares reserved for issuance under our equity incentive plan, of which 1,374,651 shares were available for issuance. | text | 4521922 | sharesItemType | text: <entity> 4521922 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there were 4,521,922 shares reserved for issuance under our equity incentive plan, of which 1,374,651 shares were available for issuance. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
As of December 31, 2024, there were 4,521,922 shares reserved for issuance under our equity incentive plan, of which 1,374,651 shares were available for issuance. | text | 1374651 | sharesItemType | text: <entity> 1374651 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there were 4,521,922 shares reserved for issuance under our equity incentive plan, of which 1,374,651 shares were available for issuance. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
Stock options are granted to employees at the exercise price, which is equal to the closing price of our stock on the date of grant. The stock options include a four-year service period and 25 % vest after the first year of service and the remainder vest in equal monthly installments over the next 36 months of service. Options are forfeitable in the event of termination other than for death, disability, or qualifying retirement. Upon death or disability, all outstanding and unvested options accelerate and become fully vested. Upon qualifying retirement, all outstanding and unvested options accelerate, become fully vested, and become exercisable in accordance with the original grant terms. The stock options have a contractual life of ten years . | text | 25 | percentItemType | text: <entity> 25 </entity> <entity type> percentItemType </entity type> <context> Stock options are granted to employees at the exercise price, which is equal to the closing price of our stock on the date of grant. The stock options include a four-year service period and 25 % vest after the first year of service and the remainder vest in equal monthly installments over the next 36 months of service. Options are forfeitable in the event of termination other than for death, disability, or qualifying retirement. Upon death or disability, all outstanding and unvested options accelerate and become fully vested. Upon qualifying retirement, all outstanding and unvested options accelerate, become fully vested, and become exercisable in accordance with the original grant terms. The stock options have a contractual life of ten years . </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of our common stock at the date of exercise and the exercise price for those options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The total grant date fair value of options vested during the year was $ 56.7 million, $ 45.7 million and $ 30.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. As of December 31, 2024, the amount of unearned stock-based compensation currently estimated to be expensed from now through the year 2028 related to unvested stock options is $ 68.0 million which we expect to recognize over a weighted average period of 2.2 years. | text | 56.7 | monetaryItemType | text: <entity> 56.7 </entity> <entity type> monetaryItemType </entity type> <context> The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of our common stock at the date of exercise and the exercise price for those options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The total grant date fair value of options vested during the year was $ 56.7 million, $ 45.7 million and $ 30.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. As of December 31, 2024, the amount of unearned stock-based compensation currently estimated to be expensed from now through the year 2028 related to unvested stock options is $ 68.0 million which we expect to recognize over a weighted average period of 2.2 years. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of our common stock at the date of exercise and the exercise price for those options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The total grant date fair value of options vested during the year was $ 56.7 million, $ 45.7 million and $ 30.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. As of December 31, 2024, the amount of unearned stock-based compensation currently estimated to be expensed from now through the year 2028 related to unvested stock options is $ 68.0 million which we expect to recognize over a weighted average period of 2.2 years. | text | 45.7 | monetaryItemType | text: <entity> 45.7 </entity> <entity type> monetaryItemType </entity type> <context> The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of our common stock at the date of exercise and the exercise price for those options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The total grant date fair value of options vested during the year was $ 56.7 million, $ 45.7 million and $ 30.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. As of December 31, 2024, the amount of unearned stock-based compensation currently estimated to be expensed from now through the year 2028 related to unvested stock options is $ 68.0 million which we expect to recognize over a weighted average period of 2.2 years. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of our common stock at the date of exercise and the exercise price for those options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The total grant date fair value of options vested during the year was $ 56.7 million, $ 45.7 million and $ 30.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. As of December 31, 2024, the amount of unearned stock-based compensation currently estimated to be expensed from now through the year 2028 related to unvested stock options is $ 68.0 million which we expect to recognize over a weighted average period of 2.2 years. | text | 30.6 | monetaryItemType | text: <entity> 30.6 </entity> <entity type> monetaryItemType </entity type> <context> The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of our common stock at the date of exercise and the exercise price for those options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The total grant date fair value of options vested during the year was $ 56.7 million, $ 45.7 million and $ 30.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. As of December 31, 2024, the amount of unearned stock-based compensation currently estimated to be expensed from now through the year 2028 related to unvested stock options is $ 68.0 million which we expect to recognize over a weighted average period of 2.2 years. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of our common stock at the date of exercise and the exercise price for those options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The total grant date fair value of options vested during the year was $ 56.7 million, $ 45.7 million and $ 30.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. As of December 31, 2024, the amount of unearned stock-based compensation currently estimated to be expensed from now through the year 2028 related to unvested stock options is $ 68.0 million which we expect to recognize over a weighted average period of 2.2 years. | text | 68.0 | monetaryItemType | text: <entity> 68.0 </entity> <entity type> monetaryItemType </entity type> <context> The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of our common stock at the date of exercise and the exercise price for those options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The total grant date fair value of options vested during the year was $ 56.7 million, $ 45.7 million and $ 30.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. As of December 31, 2024, the amount of unearned stock-based compensation currently estimated to be expensed from now through the year 2028 related to unvested stock options is $ 68.0 million which we expect to recognize over a weighted average period of 2.2 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions |
The aggregate intrinsic value of unvested RSUs was based on our closing stock price on the last trading day of the period. The aggregate intrinsic value of vested RSUs was based on our closing stock price on the date of vest. As of December 31, 2024, the amount of unearned stock-based compensation currently estimated to be expensed from now through the year 2027 related to unvested RSUs is $ 95.5 million which we expect to recognize over a weighted average period of 2.1 years. | text | 95.5 | monetaryItemType | text: <entity> 95.5 </entity> <entity type> monetaryItemType </entity type> <context> The aggregate intrinsic value of unvested RSUs was based on our closing stock price on the last trading day of the period. The aggregate intrinsic value of vested RSUs was based on our closing stock price on the date of vest. As of December 31, 2024, the amount of unearned stock-based compensation currently estimated to be expensed from now through the year 2027 related to unvested RSUs is $ 95.5 million which we expect to recognize over a weighted average period of 2.1 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions |
The fair value of the PSUs is equal to the closing price of our common stock on the grant date. The aggregate intrinsic value of unvested PSUs was based on our closing stock price on the last trading day of the period. As of December 31, 2024, there was $ 27.6 million of unrecognized stock-based compensation expense related to outstanding PSUs that is expected to be recognized over a weighted average period of 1.5 years. | text | 27.6 | monetaryItemType | text: <entity> 27.6 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the PSUs is equal to the closing price of our common stock on the grant date. The aggregate intrinsic value of unvested PSUs was based on our closing stock price on the last trading day of the period. As of December 31, 2024, there was $ 27.6 million of unrecognized stock-based compensation expense related to outstanding PSUs that is expected to be recognized over a weighted average period of 1.5 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions |
Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 85 % of the lower of the closing market price per share of our common stock on the first or last trading day of a purchase period. We issued 48,599 shares under the ESPP during 2024 and there were 1,199,532 shares available for future issuance under the ESPP as of December 31, 2024. | text | 85 | percentItemType | text: <entity> 85 </entity> <entity type> percentItemType </entity type> <context> Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 85 % of the lower of the closing market price per share of our common stock on the first or last trading day of a purchase period. We issued 48,599 shares under the ESPP during 2024 and there were 1,199,532 shares available for future issuance under the ESPP as of December 31, 2024. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent |
Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 85 % of the lower of the closing market price per share of our common stock on the first or last trading day of a purchase period. We issued 48,599 shares under the ESPP during 2024 and there were 1,199,532 shares available for future issuance under the ESPP as of December 31, 2024. | text | 48599 | sharesItemType | text: <entity> 48599 </entity> <entity type> sharesItemType </entity type> <context> Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 85 % of the lower of the closing market price per share of our common stock on the first or last trading day of a purchase period. We issued 48,599 shares under the ESPP during 2024 and there were 1,199,532 shares available for future issuance under the ESPP as of December 31, 2024. </context> | us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans |
Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 85 % of the lower of the closing market price per share of our common stock on the first or last trading day of a purchase period. We issued 48,599 shares under the ESPP during 2024 and there were 1,199,532 shares available for future issuance under the ESPP as of December 31, 2024. | text | 1199532 | sharesItemType | text: <entity> 1199532 </entity> <entity type> sharesItemType </entity type> <context> Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 85 % of the lower of the closing market price per share of our common stock on the first or last trading day of a purchase period. We issued 48,599 shares under the ESPP during 2024 and there were 1,199,532 shares available for future issuance under the ESPP as of December 31, 2024. </context> | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
As of December 31, 2024, we had gross federal net operating loss carryforwards, which are no longer subject to expiration, of $ 51.2 million. In addition, we had net operating loss carryforwards for state income tax purposes of $ 88.1 million which will begin to expire in 2025. We also have gross R&D credit carryforwards of $ 13.4 million as of December 31, 2024 which will expire at various dates beginning in 2034. | text | 51.2 | monetaryItemType | text: <entity> 51.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, we had gross federal net operating loss carryforwards, which are no longer subject to expiration, of $ 51.2 million. In addition, we had net operating loss carryforwards for state income tax purposes of $ 88.1 million which will begin to expire in 2025. We also have gross R&D credit carryforwards of $ 13.4 million as of December 31, 2024 which will expire at various dates beginning in 2034. </context> | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024, we had gross federal net operating loss carryforwards, which are no longer subject to expiration, of $ 51.2 million. In addition, we had net operating loss carryforwards for state income tax purposes of $ 88.1 million which will begin to expire in 2025. We also have gross R&D credit carryforwards of $ 13.4 million as of December 31, 2024 which will expire at various dates beginning in 2034. | text | 88.1 | monetaryItemType | text: <entity> 88.1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, we had gross federal net operating loss carryforwards, which are no longer subject to expiration, of $ 51.2 million. In addition, we had net operating loss carryforwards for state income tax purposes of $ 88.1 million which will begin to expire in 2025. We also have gross R&D credit carryforwards of $ 13.4 million as of December 31, 2024 which will expire at various dates beginning in 2034. </context> | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024, we had gross federal net operating loss carryforwards, which are no longer subject to expiration, of $ 51.2 million. In addition, we had net operating loss carryforwards for state income tax purposes of $ 88.1 million which will begin to expire in 2025. We also have gross R&D credit carryforwards of $ 13.4 million as of December 31, 2024 which will expire at various dates beginning in 2034. | text | 13.4 | monetaryItemType | text: <entity> 13.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, we had gross federal net operating loss carryforwards, which are no longer subject to expiration, of $ 51.2 million. In addition, we had net operating loss carryforwards for state income tax purposes of $ 88.1 million which will begin to expire in 2025. We also have gross R&D credit carryforwards of $ 13.4 million as of December 31, 2024 which will expire at various dates beginning in 2034. </context> | us-gaap:TaxCreditCarryforwardAmount |
Utilization of the net operating loss carryforwards and R&D credit carryforwards may be subject to an annual limitation due to the ownership change limitations provided by Section 382 and Section 383 of the Code and similar state provisions. During 2024, we finalized a detailed analysis to determine whether an ownership change has occurred through December 31, 2023, and if a limitation exists. It was determined that December 11, 2018 was the only date that we experienced an ownership change. The study concluded that none of the $ 126.5 million of federal net operating losses nor the $ 1.7 million of federal R&D credits that were accumulated on December 11, 2018 will expire unused solely due to the limitations under Sections 382 and 383 of the Code. We are in the process of updating the analysis through December 31, 2024. Although unexpected, if we experienced an ownership change during 2024, the timing of our ability to utilize the tax attributes may be affected. | text | 126.5 | monetaryItemType | text: <entity> 126.5 </entity> <entity type> monetaryItemType </entity type> <context> Utilization of the net operating loss carryforwards and R&D credit carryforwards may be subject to an annual limitation due to the ownership change limitations provided by Section 382 and Section 383 of the Code and similar state provisions. During 2024, we finalized a detailed analysis to determine whether an ownership change has occurred through December 31, 2023, and if a limitation exists. It was determined that December 11, 2018 was the only date that we experienced an ownership change. The study concluded that none of the $ 126.5 million of federal net operating losses nor the $ 1.7 million of federal R&D credits that were accumulated on December 11, 2018 will expire unused solely due to the limitations under Sections 382 and 383 of the Code. We are in the process of updating the analysis through December 31, 2024. Although unexpected, if we experienced an ownership change during 2024, the timing of our ability to utilize the tax attributes may be affected. </context> | us-gaap:OperatingLossCarryforwards |
Utilization of the net operating loss carryforwards and R&D credit carryforwards may be subject to an annual limitation due to the ownership change limitations provided by Section 382 and Section 383 of the Code and similar state provisions. During 2024, we finalized a detailed analysis to determine whether an ownership change has occurred through December 31, 2023, and if a limitation exists. It was determined that December 11, 2018 was the only date that we experienced an ownership change. The study concluded that none of the $ 126.5 million of federal net operating losses nor the $ 1.7 million of federal R&D credits that were accumulated on December 11, 2018 will expire unused solely due to the limitations under Sections 382 and 383 of the Code. We are in the process of updating the analysis through December 31, 2024. Although unexpected, if we experienced an ownership change during 2024, the timing of our ability to utilize the tax attributes may be affected. | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> Utilization of the net operating loss carryforwards and R&D credit carryforwards may be subject to an annual limitation due to the ownership change limitations provided by Section 382 and Section 383 of the Code and similar state provisions. During 2024, we finalized a detailed analysis to determine whether an ownership change has occurred through December 31, 2023, and if a limitation exists. It was determined that December 11, 2018 was the only date that we experienced an ownership change. The study concluded that none of the $ 126.5 million of federal net operating losses nor the $ 1.7 million of federal R&D credits that were accumulated on December 11, 2018 will expire unused solely due to the limitations under Sections 382 and 383 of the Code. We are in the process of updating the analysis through December 31, 2024. Although unexpected, if we experienced an ownership change during 2024, the timing of our ability to utilize the tax attributes may be affected. </context> | us-gaap:TaxCreditCarryforwardAmount |
Realization of the deferred tax assets is dependent upon the generation of future book income, if any, the amount and timing of which are uncertain. Based on available objective evidence and cumulative losses, we believe it is more likely than not that the deferred tax assets are not recognizable and will not be recognizable until we have sufficient book income. Accordingly, the net deferred tax assets have been offset by a valuation allowance, with the exception of less than $ 0.1 million in foreign deferred tax assets. The valuation allowance decreased by $ 9.9 million and increased by $ 12.9 million during the years ended December 31, 2024 and 2023, respectively. | text | 0.1 | monetaryItemType | text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> Realization of the deferred tax assets is dependent upon the generation of future book income, if any, the amount and timing of which are uncertain. Based on available objective evidence and cumulative losses, we believe it is more likely than not that the deferred tax assets are not recognizable and will not be recognizable until we have sufficient book income. Accordingly, the net deferred tax assets have been offset by a valuation allowance, with the exception of less than $ 0.1 million in foreign deferred tax assets. The valuation allowance decreased by $ 9.9 million and increased by $ 12.9 million during the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign |
Realization of the deferred tax assets is dependent upon the generation of future book income, if any, the amount and timing of which are uncertain. Based on available objective evidence and cumulative losses, we believe it is more likely than not that the deferred tax assets are not recognizable and will not be recognizable until we have sufficient book income. Accordingly, the net deferred tax assets have been offset by a valuation allowance, with the exception of less than $ 0.1 million in foreign deferred tax assets. The valuation allowance decreased by $ 9.9 million and increased by $ 12.9 million during the years ended December 31, 2024 and 2023, respectively. | text | 9.9 | monetaryItemType | text: <entity> 9.9 </entity> <entity type> monetaryItemType </entity type> <context> Realization of the deferred tax assets is dependent upon the generation of future book income, if any, the amount and timing of which are uncertain. Based on available objective evidence and cumulative losses, we believe it is more likely than not that the deferred tax assets are not recognizable and will not be recognizable until we have sufficient book income. Accordingly, the net deferred tax assets have been offset by a valuation allowance, with the exception of less than $ 0.1 million in foreign deferred tax assets. The valuation allowance decreased by $ 9.9 million and increased by $ 12.9 million during the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
Realization of the deferred tax assets is dependent upon the generation of future book income, if any, the amount and timing of which are uncertain. Based on available objective evidence and cumulative losses, we believe it is more likely than not that the deferred tax assets are not recognizable and will not be recognizable until we have sufficient book income. Accordingly, the net deferred tax assets have been offset by a valuation allowance, with the exception of less than $ 0.1 million in foreign deferred tax assets. The valuation allowance decreased by $ 9.9 million and increased by $ 12.9 million during the years ended December 31, 2024 and 2023, respectively. | text | 12.9 | monetaryItemType | text: <entity> 12.9 </entity> <entity type> monetaryItemType </entity type> <context> Realization of the deferred tax assets is dependent upon the generation of future book income, if any, the amount and timing of which are uncertain. Based on available objective evidence and cumulative losses, we believe it is more likely than not that the deferred tax assets are not recognizable and will not be recognizable until we have sufficient book income. Accordingly, the net deferred tax assets have been offset by a valuation allowance, with the exception of less than $ 0.1 million in foreign deferred tax assets. The valuation allowance decreased by $ 9.9 million and increased by $ 12.9 million during the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
We file income tax returns in the applicable jurisdictions. The 2020 to 2023 tax years remain open to examination by the major taxing authorities to which we are subject. We do no t expect a significant change to our unrecognized tax positions over the next 12 months. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> We file income tax returns in the applicable jurisdictions. The 2020 to 2023 tax years remain open to examination by the major taxing authorities to which we are subject. We do no t expect a significant change to our unrecognized tax positions over the next 12 months. </context> | us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit |
We operate our business as one operating segment. An operating segment is defined as a component of an enterprise for which separate discrete financial information is available and evaluated regularly by the chief operating decision maker ("CODM") in deciding how to allocate resources and in assessing performance. Our CODM is the Company's President, Chief Executive Officer, and Chair of the Board of Directors. Reportable segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance. Our segment revenues are derived from the sales of our product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in select countries in Europe and the Asia Pacific region. We do not have any intra-entity sales or transfers. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> We operate our business as one operating segment. An operating segment is defined as a component of an enterprise for which separate discrete financial information is available and evaluated regularly by the chief operating decision maker ("CODM") in deciding how to allocate resources and in assessing performance. Our CODM is the Company's President, Chief Executive Officer, and Chair of the Board of Directors. Reportable segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance. Our segment revenues are derived from the sales of our product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in select countries in Europe and the Asia Pacific region. We do not have any intra-entity sales or transfers. </context> | us-gaap:NumberOfOperatingSegments |
For the years ended December 31, 2024, 2023, and 2022, depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. | text | 6.6 | monetaryItemType | text: <entity> 6.6 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022, depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. </context> | us-gaap:DepreciationAndAmortization |
For the years ended December 31, 2024, 2023, and 2022, depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022, depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. </context> | us-gaap:DepreciationAndAmortization |
For the years ended December 31, 2024, 2023, and 2022, depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. | text | 1.9 | monetaryItemType | text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022, depreciation and amortization expense was $ 6.6 million, $ 2.8 million, and $ 1.9 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. </context> | us-gaap:DepreciationAndAmortization |
For the years ended December 31, 2024, 2023, and 2022, stock-based compensation expense was $ 116.0 million, $ 82.5 million and $ 52.0 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. | text | 116.0 | monetaryItemType | text: <entity> 116.0 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022, stock-based compensation expense was $ 116.0 million, $ 82.5 million and $ 52.0 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. </context> | us-gaap:ShareBasedCompensation |
For the years ended December 31, 2024, 2023, and 2022, stock-based compensation expense was $ 116.0 million, $ 82.5 million and $ 52.0 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. | text | 82.5 | monetaryItemType | text: <entity> 82.5 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022, stock-based compensation expense was $ 116.0 million, $ 82.5 million and $ 52.0 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. </context> | us-gaap:ShareBasedCompensation |
For the years ended December 31, 2024, 2023, and 2022, stock-based compensation expense was $ 116.0 million, $ 82.5 million and $ 52.0 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. | text | 52.0 | monetaryItemType | text: <entity> 52.0 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022, stock-based compensation expense was $ 116.0 million, $ 82.5 million and $ 52.0 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative expense. </context> | us-gaap:ShareBasedCompensation |
In December 2023, we entered into an agreement with an entity controlled by our CEO (the "Entity"), pursuant to which we agreed to share the costs of a corporate suite at a sports and entertainment venue (the "Venue") (the “Suite”) (the “Cost Sharing Agreement”). In August 2023, the Entity entered into an agreement with the Venue, pursuant to which the Entity acquired certain rights to use the Suite for specified sporting and other events at the Venue through August 2026. Pursuant to this agreement, the Entity agreed to pay $ 0.2 million per year, with each year beginning September 1 and ending August 31, and the fee increasing by 5 % for each succeeding year. Under the Cost Sharing Agreement, we will reimburse the Entity 50 % of the cost of the Suite in exchange for the right to use the Suite for 50 % of the specified events at the Venue through August 2026. We recognized expense of $ 0.2 million and less than $ 0.1 million for the use of the suite in SG&A expense in our consolidated statements of operations and comprehensive income (loss) for the years ended December 31, 2024 and 2023, respectively. | text | 0.2 | monetaryItemType | text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> In December 2023, we entered into an agreement with an entity controlled by our CEO (the "Entity"), pursuant to which we agreed to share the costs of a corporate suite at a sports and entertainment venue (the "Venue") (the “Suite”) (the “Cost Sharing Agreement”). In August 2023, the Entity entered into an agreement with the Venue, pursuant to which the Entity acquired certain rights to use the Suite for specified sporting and other events at the Venue through August 2026. Pursuant to this agreement, the Entity agreed to pay $ 0.2 million per year, with each year beginning September 1 and ending August 31, and the fee increasing by 5 % for each succeeding year. Under the Cost Sharing Agreement, we will reimburse the Entity 50 % of the cost of the Suite in exchange for the right to use the Suite for 50 % of the specified events at the Venue through August 2026. We recognized expense of $ 0.2 million and less than $ 0.1 million for the use of the suite in SG&A expense in our consolidated statements of operations and comprehensive income (loss) for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:RelatedPartyTransactionAmountsOfTransaction |
In December 2023, we entered into an agreement with an entity controlled by our CEO (the "Entity"), pursuant to which we agreed to share the costs of a corporate suite at a sports and entertainment venue (the "Venue") (the “Suite”) (the “Cost Sharing Agreement”). In August 2023, the Entity entered into an agreement with the Venue, pursuant to which the Entity acquired certain rights to use the Suite for specified sporting and other events at the Venue through August 2026. Pursuant to this agreement, the Entity agreed to pay $ 0.2 million per year, with each year beginning September 1 and ending August 31, and the fee increasing by 5 % for each succeeding year. Under the Cost Sharing Agreement, we will reimburse the Entity 50 % of the cost of the Suite in exchange for the right to use the Suite for 50 % of the specified events at the Venue through August 2026. We recognized expense of $ 0.2 million and less than $ 0.1 million for the use of the suite in SG&A expense in our consolidated statements of operations and comprehensive income (loss) for the years ended December 31, 2024 and 2023, respectively. | text | 0.1 | monetaryItemType | text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> In December 2023, we entered into an agreement with an entity controlled by our CEO (the "Entity"), pursuant to which we agreed to share the costs of a corporate suite at a sports and entertainment venue (the "Venue") (the “Suite”) (the “Cost Sharing Agreement”). In August 2023, the Entity entered into an agreement with the Venue, pursuant to which the Entity acquired certain rights to use the Suite for specified sporting and other events at the Venue through August 2026. Pursuant to this agreement, the Entity agreed to pay $ 0.2 million per year, with each year beginning September 1 and ending August 31, and the fee increasing by 5 % for each succeeding year. Under the Cost Sharing Agreement, we will reimburse the Entity 50 % of the cost of the Suite in exchange for the right to use the Suite for 50 % of the specified events at the Venue through August 2026. We recognized expense of $ 0.2 million and less than $ 0.1 million for the use of the suite in SG&A expense in our consolidated statements of operations and comprehensive income (loss) for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:RelatedPartyTransactionAmountsOfTransaction |
With operations in over 15 countries, we are a global provider of drilling and drilling-related services for land-based and offshore oil and natural gas wells, with a fleet of rigs and drilling-related equipment which, as of December 31, 2024 included: | text | 15 | integerItemType | text: <entity> 15 </entity> <entity type> integerItemType </entity type> <context> With operations in over 15 countries, we are a global provider of drilling and drilling-related services for land-based and offshore oil and natural gas wells, with a fleet of rigs and drilling-related equipment which, as of December 31, 2024 included: </context> | us-gaap:NumberOfCountriesInWhichEntityOperates |
The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. | text | 0.7 | percentItemType | text: <entity> 0.7 </entity> <entity type> percentItemType </entity type> <context> The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. </context> | us-gaap:ConcentrationRiskPercentage1 |
The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. | text | 0.9 | percentItemType | text: <entity> 0.9 </entity> <entity type> percentItemType </entity type> <context> The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. </context> | us-gaap:ConcentrationRiskPercentage1 |
The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. | text | 1.1 | percentItemType | text: <entity> 1.1 </entity> <entity type> percentItemType </entity type> <context> The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. </context> | us-gaap:ConcentrationRiskPercentage1 |
The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. | text | no | percentItemType | text: <entity> no </entity> <entity type> percentItemType </entity type> <context> The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. </context> | us-gaap:ConcentrationRiskPercentage1 |
Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out or weighted-average costs methods and includes the cost of materials, labor and manufacturing overhead. Inventory, which is presented net of reserves of $ 24.3 million and $ 23.9 million as of December 31, 2024 and 2023, respectively, included the following: | text | 24.3 | monetaryItemType | text: <entity> 24.3 </entity> <entity type> monetaryItemType </entity type> <context> Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out or weighted-average costs methods and includes the cost of materials, labor and manufacturing overhead. Inventory, which is presented net of reserves of $ 24.3 million and $ 23.9 million as of December 31, 2024 and 2023, respectively, included the following: </context> | us-gaap:InventoryAdjustments |
Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out or weighted-average costs methods and includes the cost of materials, labor and manufacturing overhead. Inventory, which is presented net of reserves of $ 24.3 million and $ 23.9 million as of December 31, 2024 and 2023, respectively, included the following: | text | 23.9 | monetaryItemType | text: <entity> 23.9 </entity> <entity type> monetaryItemType </entity type> <context> Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out or weighted-average costs methods and includes the cost of materials, labor and manufacturing overhead. Inventory, which is presented net of reserves of $ 24.3 million and $ 23.9 million as of December 31, 2024 and 2023, respectively, included the following: </context> | us-gaap:InventoryAdjustments |
The Company entered into an accounts receivable sales agreement (the “A/R Sales Agreement”) and an accounts receivable purchase agreement (the “A/R Purchase Agreement,” and, together with the A/R Sales Agreement, the “A/R Agreements”). As part of the A/R Agreements, the Company continuously sells designated eligible pools of receivables as they are originated by it and certain of its U.S. subsidiaries to a separate, bankruptcy-remote, special purpose entity (“SPE”) pursuant to the A/R Sales Agreement. Pursuant to the A/R Purchase Agreement, the SPE in turn sells, transfers, conveys and assigns to unaffiliated third-party financial institutions (the “Purchasers”) all the rights, title and interest in and to its pool of eligible receivables (the “Eligible Receivables”). The sale of the Eligible Receivables qualifies for sale accounting treatment in accordance with ASC 860 – Transfers and Servicing. During the period of this program, cash receipts from the Purchasers at the time of the sale are classified as operating activities in our consolidated statement of cash flows and the associated receivables are derecognized from the Company’s consolidated balance sheet at the time of the sale. The remaining receivables held by the SPE were pledged to secure the collectability of the sold Eligible Receivables. Subsequent collections on the pledged receivables, which have not been sold, will be classified as operating cash flows in our consolidated statement of cash flows at the time of collection. The amount of receivables pledged as collateral as of December 31, 2024 and 2023 is approximately $ 44.6 million and $ 67.0 million, respectively. | text | 44.6 | monetaryItemType | text: <entity> 44.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an accounts receivable sales agreement (the “A/R Sales Agreement”) and an accounts receivable purchase agreement (the “A/R Purchase Agreement,” and, together with the A/R Sales Agreement, the “A/R Agreements”). As part of the A/R Agreements, the Company continuously sells designated eligible pools of receivables as they are originated by it and certain of its U.S. subsidiaries to a separate, bankruptcy-remote, special purpose entity (“SPE”) pursuant to the A/R Sales Agreement. Pursuant to the A/R Purchase Agreement, the SPE in turn sells, transfers, conveys and assigns to unaffiliated third-party financial institutions (the “Purchasers”) all the rights, title and interest in and to its pool of eligible receivables (the “Eligible Receivables”). The sale of the Eligible Receivables qualifies for sale accounting treatment in accordance with ASC 860 – Transfers and Servicing. During the period of this program, cash receipts from the Purchasers at the time of the sale are classified as operating activities in our consolidated statement of cash flows and the associated receivables are derecognized from the Company’s consolidated balance sheet at the time of the sale. The remaining receivables held by the SPE were pledged to secure the collectability of the sold Eligible Receivables. Subsequent collections on the pledged receivables, which have not been sold, will be classified as operating cash flows in our consolidated statement of cash flows at the time of collection. The amount of receivables pledged as collateral as of December 31, 2024 and 2023 is approximately $ 44.6 million and $ 67.0 million, respectively. </context> | us-gaap:AccountsReceivableGross |
The Company entered into an accounts receivable sales agreement (the “A/R Sales Agreement”) and an accounts receivable purchase agreement (the “A/R Purchase Agreement,” and, together with the A/R Sales Agreement, the “A/R Agreements”). As part of the A/R Agreements, the Company continuously sells designated eligible pools of receivables as they are originated by it and certain of its U.S. subsidiaries to a separate, bankruptcy-remote, special purpose entity (“SPE”) pursuant to the A/R Sales Agreement. Pursuant to the A/R Purchase Agreement, the SPE in turn sells, transfers, conveys and assigns to unaffiliated third-party financial institutions (the “Purchasers”) all the rights, title and interest in and to its pool of eligible receivables (the “Eligible Receivables”). The sale of the Eligible Receivables qualifies for sale accounting treatment in accordance with ASC 860 – Transfers and Servicing. During the period of this program, cash receipts from the Purchasers at the time of the sale are classified as operating activities in our consolidated statement of cash flows and the associated receivables are derecognized from the Company’s consolidated balance sheet at the time of the sale. The remaining receivables held by the SPE were pledged to secure the collectability of the sold Eligible Receivables. Subsequent collections on the pledged receivables, which have not been sold, will be classified as operating cash flows in our consolidated statement of cash flows at the time of collection. The amount of receivables pledged as collateral as of December 31, 2024 and 2023 is approximately $ 44.6 million and $ 67.0 million, respectively. | text | 67.0 | monetaryItemType | text: <entity> 67.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an accounts receivable sales agreement (the “A/R Sales Agreement”) and an accounts receivable purchase agreement (the “A/R Purchase Agreement,” and, together with the A/R Sales Agreement, the “A/R Agreements”). As part of the A/R Agreements, the Company continuously sells designated eligible pools of receivables as they are originated by it and certain of its U.S. subsidiaries to a separate, bankruptcy-remote, special purpose entity (“SPE”) pursuant to the A/R Sales Agreement. Pursuant to the A/R Purchase Agreement, the SPE in turn sells, transfers, conveys and assigns to unaffiliated third-party financial institutions (the “Purchasers”) all the rights, title and interest in and to its pool of eligible receivables (the “Eligible Receivables”). The sale of the Eligible Receivables qualifies for sale accounting treatment in accordance with ASC 860 – Transfers and Servicing. During the period of this program, cash receipts from the Purchasers at the time of the sale are classified as operating activities in our consolidated statement of cash flows and the associated receivables are derecognized from the Company’s consolidated balance sheet at the time of the sale. The remaining receivables held by the SPE were pledged to secure the collectability of the sold Eligible Receivables. Subsequent collections on the pledged receivables, which have not been sold, will be classified as operating cash flows in our consolidated statement of cash flows at the time of collection. The amount of receivables pledged as collateral as of December 31, 2024 and 2023 is approximately $ 44.6 million and $ 67.0 million, respectively. </context> | us-gaap:AccountsReceivableGross |
The amount available for sale to the Purchasers under the A/R Purchase Agreement fluctuates over time based on the total amount of Eligible Receivables generated during the normal course of business after excluding excess concentrations and certain other ineligible receivables. As of December 31, 2024 and 2023, approximately $ 130.0 million and $ 145.0 million had been sold to and as yet uncollected by the Purchasers, respectively. | text | 130.0 | monetaryItemType | text: <entity> 130.0 </entity> <entity type> monetaryItemType </entity type> <context> The amount available for sale to the Purchasers under the A/R Purchase Agreement fluctuates over time based on the total amount of Eligible Receivables generated during the normal course of business after excluding excess concentrations and certain other ineligible receivables. As of December 31, 2024 and 2023, approximately $ 130.0 million and $ 145.0 million had been sold to and as yet uncollected by the Purchasers, respectively. </context> | us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized |
The amount available for sale to the Purchasers under the A/R Purchase Agreement fluctuates over time based on the total amount of Eligible Receivables generated during the normal course of business after excluding excess concentrations and certain other ineligible receivables. As of December 31, 2024 and 2023, approximately $ 130.0 million and $ 145.0 million had been sold to and as yet uncollected by the Purchasers, respectively. | text | 145.0 | monetaryItemType | text: <entity> 145.0 </entity> <entity type> monetaryItemType </entity type> <context> The amount available for sale to the Purchasers under the A/R Purchase Agreement fluctuates over time based on the total amount of Eligible Receivables generated during the normal course of business after excluding excess concentrations and certain other ineligible receivables. As of December 31, 2024 and 2023, approximately $ 130.0 million and $ 145.0 million had been sold to and as yet uncollected by the Purchasers, respectively. </context> | us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized |
On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. | text | 42.70 | perShareItemType | text: <entity> 42.70 </entity> <entity type> perShareItemType </entity type> <context> On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. </context> | us-gaap:BusinessAcquisitionSharePrice |
On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. | text | 99.62 | perShareItemType | text: <entity> 99.62 </entity> <entity type> perShareItemType </entity type> <context> On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. </context> | us-gaap:BusinessAcquisitionSharePrice |
On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. | text | 478176000 | monetaryItemType | text: <entity> 478176000 </entity> <entity type> monetaryItemType </entity type> <context> On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. </context> | us-gaap:BusinessCombinationPriceOfAcquisitionExpected |
Total share-based compensation expense, which includes stock options and restricted shares, was $ 16.5 million, $ 15.8 million and $ 15.8 million for 2024, 2023 and 2022, respectively. Compensation expense related to awards of restricted shares totaled $ 16.5 million, $ 15.8 million and $ 15.8 million 2024, 2023 and 2022, respectively, which is included in general and administrative and research and engineering expenses in our consolidated statements of income (loss). Share-based compensation expense has been allocated to our various reportable segments. See Note 17—Segment Information. | text | 16.5 | monetaryItemType | text: <entity> 16.5 </entity> <entity type> monetaryItemType </entity type> <context> Total share-based compensation expense, which includes stock options and restricted shares, was $ 16.5 million, $ 15.8 million and $ 15.8 million for 2024, 2023 and 2022, respectively. Compensation expense related to awards of restricted shares totaled $ 16.5 million, $ 15.8 million and $ 15.8 million 2024, 2023 and 2022, respectively, which is included in general and administrative and research and engineering expenses in our consolidated statements of income (loss). Share-based compensation expense has been allocated to our various reportable segments. See Note 17—Segment Information. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
Total share-based compensation expense, which includes stock options and restricted shares, was $ 16.5 million, $ 15.8 million and $ 15.8 million for 2024, 2023 and 2022, respectively. Compensation expense related to awards of restricted shares totaled $ 16.5 million, $ 15.8 million and $ 15.8 million 2024, 2023 and 2022, respectively, which is included in general and administrative and research and engineering expenses in our consolidated statements of income (loss). Share-based compensation expense has been allocated to our various reportable segments. See Note 17—Segment Information. | text | 15.8 | monetaryItemType | text: <entity> 15.8 </entity> <entity type> monetaryItemType </entity type> <context> Total share-based compensation expense, which includes stock options and restricted shares, was $ 16.5 million, $ 15.8 million and $ 15.8 million for 2024, 2023 and 2022, respectively. Compensation expense related to awards of restricted shares totaled $ 16.5 million, $ 15.8 million and $ 15.8 million 2024, 2023 and 2022, respectively, which is included in general and administrative and research and engineering expenses in our consolidated statements of income (loss). Share-based compensation expense has been allocated to our various reportable segments. See Note 17—Segment Information. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.